Beyondspring Inc. cash flow statement
In fiscal 2025, Beyondspring Inc.'s operations generated −$19.8m of cash; it spent $50,000 on capital projects, leaving free cash flow of −$19.8m.
Cash flow statement
| Fiscal year | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −1 | −7 | −14 | −29 | −40 | −48 | −44 | −47 | −27 | −16 | −16 | −20 | −17 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 |
| Stock-based pay | — | — | — | 23 | 7 | 2 | 8 | 3 | 2 | 1 | 2 | 1 | 1 |
| Capital spending | — | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | — | −7 | −14 | −29 | −40 | −48 | −44 | −50 | −27 | −17 | −17 | −20 | −17 |
| Free cash flow after stock pay | — | — | — | −52 | −47 | −50 | −52 | −53 | −29 | −17 | −19 | −21 | −18 |
| Shares issued | — | 16 | 15 | 51 | 14 | 69 | 113 | 0 | 0 | 0 | 3 | 2 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −5,171 | 982 | −4,198 | −5,874 | −4,193 | −5,504 | −3,277 | −3,772 |
| Depreciation and amortisation | 83 | 20 | 80 | 82 | 81 | −156 | 19 | 19 |
| Stock-based pay | 827 | 399 | 244 | 145 | 166 | 167 | 461 | 575 |
| Capital spending | 197 | 27 | 50 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −5,368 | 955 | −4,248 | −5,874 | −4,193 | −5,504 | −3,277 | −3,772 |
| Free cash flow after stock pay | −6,195 | 556 | −4,492 | −6,019 | −4,359 | −5,671 | −3,738 | −4,347 |
| Shares issued | 0 | 0 | — | — | 0 | 2,000 | — | — |
More: Biotechnology stocks compared, Health Care sector, rankings of US companies